Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 2, 2011, Pages 109-119

  Karkare, Swapna U ^a   Bhattacharjee, Sandipan ^a   Kamble, Pravin ^a   Aparasu, Rajender ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

antidepressants; depression; elderly; nursing home

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SEROTONIN AGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGED; ANXIETY; ARTICLE; DECISION MAKING; DEMOGRAPHY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; NURSING HOME; NURSING HOME PATIENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSION; FEMALE; HEALTH CARE SURVEYS; HUMANS; LOGISTIC MODELS; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; UNITED STATES;

EID: 79955942089     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.03.001     Document Type: Article

References (62)

1. Kallenbach LE, Rigler SK. Identification and management of depression in nursing facility residents. J Am Med Dir Assoc. 2006;7:448-455. (Pubitemid 44341121)
2. Jongenelis K, Pot AM, Eisses AM, et al. Prevalence and risk indicators of depression in elderly nursing home patients: the AGED study. J Affect Disord. 2004;83:135-142. (Pubitemid 39536187)
3. American Geriatrics Society; American Association for Geriatric Psychiatry. The American Geriatrics Society and American Association for Geriatric Psychiatry recommendations for policies in support of quality mental health care in US nursing homes. J Am Geriatr Soc. 2003;51:1299-1304.
4. Kaldy J, Tarnove L. A clinical practice guideline approach to treating depression in long-term care. J Am Med Dir Assoc. 2002;3:103-110. (Pubitemid 34256816)
5. Bruce ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry. 2002;52:175-184. (Pubitemid 35232086)
6. Stek ML, Gussekloo J, Beekman ATF, et al. Prevalence, correlates and recognition of depression in the oldest old: the Leiden 85-plus study. J Affect Disord. 2004;78:193-200. (Pubitemid 38167737)
7. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58(3):249-265. (Pubitemid 36307597)
8. Schulz R., Drayer RA. Rollman BL. Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry. 2002;52:205-225. (Pubitemid 35232089)
9. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet.1997;349:1498-1504.
10. Levin CA, Wei W, Akincigil A, et.al. Prevalence and treatment of diagnosed depression among elderly nursing home residents in Ohio. JAmMed Dir Assoc. 2007;8:585-594. (Pubitemid 350079964)
11. Jones RN, Marcantonio ER, Rabinowitz T. Prevalence and correlates of recognized depression in U.S. nursing homes. J Am Geriatr Soc. 2003;51:1404-1409. (Pubitemid 37259869)
12. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA. 1992;268:1018-1024.
13. Schnelle JF, Wood S, Schnelle ER, Simmons SF. Measurement sensitivity and the minimum data set depression quality indicator. Gerontologist. 2001;41:401-405. (Pubitemid 32525557)
14. Teresi J, Abrams R, Holmes D, Ramirez M, Eimicke J. Prevalence of depression and depression recognition in nursing homes. Soc Psychiatry Psychiatr Epidemiol. 2001;36:613-620. (Pubitemid 34093048)
15. NIH consensus conference. Diagnosis and treatment of depression in late life. JAMA. 1992;268:1018-1024.
16. Brown MN, Lapane KL, Luisi AF. The management of depression in older nursing home residents. J Am Geriatr Soc. 2002;50:69-76. (Pubitemid 34053025)
17. Gallo JJ, Ryan SD, Ford DE. Attitudes, knowledge and behavior of family physicians regarding depression in late life. Arch Fam Med. 1999;8:249-256.
18. United States. Public Law No. 100-203, Omnibus Budget Reconciliation Act of 1987, 22 December 1987. Annu Rev Popul Law. 1987;14:473-475.
19. Hansen DG, Rosholm JU, Gichangi A, Vach W. Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above. Age Ageing. 2007;36:449-454. (Pubitemid 47261039)
20. Khawam EA, Laurencic G, Malone DA. Side effects of antidepressants: an overview. Cleve Clin J Med. 2006;73:351-361.
21. Borson S, Doane K. The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psych Services. 1997;48:1289-1296. (Pubitemid 27415589)
22. Garrard J, Chen V, Dowd B. The impact of the 1987 Federal Regulations on the use of psychotropic drugs in Minnesota nursing homes.AmJ Public Health. 1995;85:771-776.
23. Hanlon JT, Handler SM, Castle NG. Antidepressant prescribing in U.S. nursing homes between 1996-2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc. 2010;11:320-324.
24. Foote SM, Eetheredge L. Increasing use of new prescription drugs: a case study. Health Aff (Millwood). 2000;19:165-170.
25. Pollock BG. Adverse reactions of antidepressants in elderly patients. J Clin Psychiatry. 1996;60(suppl 20):4-8.
26. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: Issues relevant to the elderly. Drugs Aging. 2008;25:501-519. (Pubitemid 351812258)
27. Thapa PB, Gideon P, Cost TW, et al. Antidepressants and risk of falls among nursing home residents. N Engl J Med. 1998;339:875-882. (Pubitemid 28446845)
28. Liu B, Anderson G, Mittman N, et al. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet. 1998;351:1303-1307. (Pubitemid 28195906)
29. Centers for Disease Control and Prevention. National Nursing Home Survey: questionnaires, datasets, and related documentation from the National Nursing Home Survey. http://www.cdc.gov/nchs/nnhs/nnhs-questionnaires.htm. Accessed March 23, 2011.
30. Koch H, Campbell W. The collection and processing of drug information: National Ambulatory Medical Care Survey - United States, 1980. Vital Health Stat. 1982;2:1-90.
31. National Nursing Home Survey: public-use data files. ftp://ftp.cdc.gov/ pub/Health-Statistics/NCHS/Datasets/NNHS/nnhs04/. Accessed March 23, 2011.
32. Bhattacharjee S, Karkare SU, Kamble P, Aparasu RA. Datapoints: psychotropic drug utilization among elderly nursing home residents in the United States. Psychiatr Serv. 2010;61:655.
33. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc. 1973;51:95-124.
34. Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic drug use among elderly nursing home residents in the United States. AmJ Geriatr Pharmacother. 2008;6:187-197.
35. Kamble P, Sherer J, Chen H, Aparasu RR. Off-label use of second-generation antipsychotic agents among elderly nursing home residents. Psychiatr Serv. 2010;61:130-136.
36. Kamble P, Chen H, Sherer J, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009;26:483-492.
37. Arthur A, Matthews R, Jagger C, Lindesay J. Factors associated with antidepressant treatment in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry. 2002;17:54-60.
38. Nishtala PS, McLachlan AJ, Bell JS, Chen TF. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. Am J Geriatr Pharmacother. 2009;7:210-219.
39. Burns BJ, Wagner HR, Taube JE, et al. Mental health services use by the elderly in nursing homes. Am J Public Health. 1993;83:331-337. (Pubitemid 23074818)
40. Shea DG, Streit A, Smyer MA. Determinants of the use of specialist mental health services by nursing home residents. Health Serv Res. 1994;29:169-185. (Pubitemid 24189432)
41. Garrard J, Makris L, Dunham T, et al. Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. JAMA. 1991;265:463-467.
42. Harrington C, Tompkins C, Curtis M, Grant L. Psychotropic drug use in long-term care facilities: a review of the literature. Gerontologist. 1992;32:822-833.
43. Borson S, Scanlan JM, Doane K, Gray S. Antidepressant prescribing in nursing homes: is there a place for tricyclics? Int J Geriatr Psychiatry. 2002;17:1140-1145. (Pubitemid 35469222)
44. Lane R, Baldwin D. Selective Serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol. 1997;17:208-221. (Pubitemid 27261777)
45. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825-1832.
46. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997;157:1531-1536. (Pubitemid 27305197)
47. Roose SP, Nelson JC, Salzman C, et al. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home. Curr Med Res Opin. 2003;19:737-746. (Pubitemid 37466144)
48. Gurvich T, Cunningham JA. Appropriate use of psychotropic drugs in nursing homes. Am Fam Physician. 2000;61:1437.
49. Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord. 1998;51:267-285. (Pubitemid 29202175)
50. Gardner ME, Malone DC, Sey M, Babington MA. Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities. J Am Med Dir Assoc. 2004;5:101-106. (Pubitemid 38380409)
51. Hosia-Randell H, Pitkälä K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging. 2005;22:793-800.
52. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2008;163:2716-2724. (Pubitemid 37517412)
53. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156:385-391. (Pubitemid 27078035)
54. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc. 2004;79:122-139. (Pubitemid 38018592)
55. Sørensen L, Foldspang A, Gulmann NC, Munk-Jørgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry. 2001;16:147-154. (Pubitemid 32166305)
56. Frank RG, Goldman HH, Hogan M. Medicaid and mental health: be careful what you ask for. Health Affairs. 2003;22:101-113. (Pubitemid 41388767)
57. Lapane KL, Hughes CM. Which organizational characteristics are associated with increased management of depression using antidepressants in US nursing homes? Med Care. 2004;42:992-1000. (Pubitemid 39530795)
58. Lenze EJ, Mulsant BH, Shear MK, et al. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry. 2000;157:722-728. (Pubitemid 30249650)
59. Flint AJ, Rifat SL. Anxious depression in elderly patients. Response to antidepressant treatment. Am J Geriatr Psychiatry. 1997;5:107-115. (Pubitemid 27157394)
60. Khawam EA., Laurencic G., Malone DA Jr. Side effects of antidepressants: an overview. Cleve Clin J Med. 2006;73:351-361.
61. Magaziner J, Miller R, Resnick B. Intervening to prevent falls and fractures in nursing homes: are we putting the cart before the horse? J Am Geriatr Soc. 2007;55:464-466. (Pubitemid 46328123)
62. Ruthazer R, Lipsitz LA. Antidepressants and falls among elderly people in long-term care. Am J Public Health. 1993:83;746-749. (Pubitemid 23143011)